BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
AnaptysBio
ANAB
$1.68B
| $72.3K | ﹤0.01% |
2,787
-10,412
| -79% | -$250K |
|
3002
Petrobras Class A
PBR.A
$104B
| $72.3K | ﹤0.01% |
6,118
-2,885
| -32% | -$28.4K |
|
3003
Peoples Bancorp
PEBO
$1.48B
| $72.2K | ﹤0.01% |
2,438
-5,938
| -71% | -$193K |
|
3004
Independent Bank Corp
IBCP
$851M
| $71.9K | ﹤0.01% |
3,314
-6,377
| -66% | -$147K |
|
3005
Protagonist Therapeutics
PTGX
$9.9B
| $71.9K | ﹤0.01% |
1,601
-3,037
| -65% | -$100K |
|
|
DHIL
3006
DELISTED
Diamond Hill
DHIL
| $71.8K | ﹤0.01% |
429
-1,020
| -70% | -$175K |
|
3007
Live Oak Bancshares
LOB
$1.99B
| $71.7K | ﹤0.01% |
1,216
-11,298
| -90% | -$709K |
|
|
SAND
3008
DELISTED
Sandstorm Gold
SAND
| $71.7K | ﹤0.01% |
+9,087
| New | +$73.6K |
|
3009
VSE Corp
VSEC
$6.7B
| $70.9K | ﹤0.01% |
1,433
-3,312
| -70% | -$152K |
|
3010
Arrow Financial
AROW
$727M
| $70.9K | ﹤0.01% |
2,156
-4,878
| -69% | -$160K |
|
3011
First Community Bankshares
FCBC
$931M
| $70.8K | ﹤0.01% |
2,371
-5,616
| -70% | -$170K |
|
3012
Ecopetrol
EC
$35.3B
| $70.7K | ﹤0.01% |
4,834
-18,895
| -80% | -$241K |
|
3013
Tilly's
TLYS
$123M
| $70.5K | ﹤0.01% |
4,412
-5,331
| -55% | -$71.8K |
|
|
MOFG
3014
DELISTED
MidWestOne Financial Group
MOFG
| $70.3K | ﹤0.01% |
2,444
-4,892
| -67% | -$150K |
|
|
CCF
3015
DELISTED
Chase Corporation
CCF
| $69.2K | ﹤0.01% |
674
-358
| -35% | -$39.6K |
|
3016
McGrath RentCorp
MGRC
$2.94B
| $68.9K | ﹤0.01% |
845
-5,640
| -87% | -$465K |
|
3017
Quanterix
QTRX
$136M
| $68.9K | ﹤0.01% |
1,175
-1,953
| -62% | -$113K |
|
3018
Allogene Therapeutics
ALLO
$704M
| $68.7K | ﹤0.01% |
2,636
-4,313
| -62% | -$123K |
|
3019
Adaptive Biotechnologies
ADPT
$3.93B
| $68.5K | ﹤0.01% |
1,676
-1,655
| -50% | -$64.3K |
|
|
EMWP
3020
DELISTED
Eros Media World PLC
EMWP
| $68.1K | ﹤0.01% |
2,226
-1,732
| -44% | -$47.3K |
|
3021
Newmark Group
NMRK
$2.73B
| $68.1K | ﹤0.01% |
5,667
-65,880
| -92% | -$789K |
|
3022
NGL Energy Partners
NGL
$2.15B
| $68K | ﹤0.01% |
28,587
-524
| -2% | -$1.17K |
|
3023
Kartoon Studios
TOON
$38.4M
| $68K | ﹤0.01% |
+3,698
| New | +$64.7K |
|
|
TRIL
3024
DELISTED
Trillium Therapeutics Inc.
TRIL
| $67.6K | ﹤0.01% |
+6,966
| New | +$65.6K |
|
3025
First Financial Corp
THFF
$977M
| $67.2K | ﹤0.01% |
1,647
-4,210
| -72% | -$187K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.